Evidence map›Paper›PMID 35211114›Full record

ArticleFrontiers in immunology2022

The Recombinant

Xiancai Du, Mingxing Zhu, Tingrui Zhang, Chan Wang, Jia Tao, Songhao Yang, Yazhou Zhu, Wei Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. miR-378a-5p targeting BRAF regulates CD4Frontiers in immunology · 2025
    Article
  3. Article
  4. Immunoprotective effect and mechanism of rEg.P29 against CD4Acta biochimica et biophysica Sinica · 2024
    Article
  5. Article
  6. Article
  7. Immunogenicity of peptide-based vaccine composed of epitopes from Echinococcus granulosus rEg.P29.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiancai DuSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Mingxing ZhuNingxia Key Laboratory of Prevention and Control of Common Infectious Diseases, Yinchuan, China.
Tingrui ZhangSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Chan WangSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Jia TaoSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Songhao YangSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Yazhou ZhuSchool of Basic Medical Science of Ningxia Medical University, Yinchuan, China.
Wei ZhaoNingxia Key Laboratory of Prevention and Control of Common Infectious Diseases, Yinchuan, China.
Ningxia Center for Diseases Prevention and Control · CNNingxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAnimalsAntigens, HelminthCalcium-Binding ProteinsCase-Control StudiesCD4-Positive T-LymphocytesCell DifferentiationEchinococcosisEchinococcus granulosusFemaleHumansMaleMiceMice, Inbred BALB CMicroRNAsMiddle AgedAntigens, HelminthCalcium-Binding ProteinsDlk1 protein, mouseMicroRNAsP-29 antigenReceptor, Notch1Vaccines, SyntheticCD4+ T cellsCystic EchinococcocosisDLK1miR-126a-5pNotch1rEg.P29Th1Th2

Identifiers

PMID35211114
PMCPMC8861942
OpenAlexW4210935115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.